CN1377696A - Chinese herbal medicine preparation for curing viral hepatitis and its preapring method - Google Patents

Chinese herbal medicine preparation for curing viral hepatitis and its preapring method Download PDF

Info

Publication number
CN1377696A
CN1377696A CN 02114047 CN02114047A CN1377696A CN 1377696 A CN1377696 A CN 1377696A CN 02114047 CN02114047 CN 02114047 CN 02114047 A CN02114047 A CN 02114047A CN 1377696 A CN1377696 A CN 1377696A
Authority
CN
China
Prior art keywords
herba
radix
viral hepatitis
fructus gardeniae
chinese herbal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 02114047
Other languages
Chinese (zh)
Inventor
杨永中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02114047 priority Critical patent/CN1377696A/en
Publication of CN1377696A publication Critical patent/CN1377696A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The Chinese herbal medicine preparation is granule prepared with capillary artemisia, negundo chastetree root, plantain, Indian kalimeris herb, glabrousleaf pittosporum root and other six kinds of Chinese medicinal materials and through decoction, concentration, filtering, drying, pelletizing and packing. It is used to treat viral hepatitis and has reliable curative effect, no toxic side effect and low cost.

Description

A kind of Chinese herbal and crude drugs preparations for the treatment of viral hepatitis and preparation method thereof
Technical field is a kind of treats medicine that viral hepatitis uses and preparation method thereof, belongs to field of Chinese herbal.
The technical background modern medicine is thought: viral hepatitis is the higher infectious disease of a kind of sickness rate that is caused by multiple hepatitis virus, and be divided into first, second, third, fourth, the eleventh of the twelve Earthly Branches five types, all with loss of appetite, weakly feel sick, hepatomegaly and liver function injury be its feature, be that HAN is in the intestinal intrusive body, enter blood, form viremia, in hepatocyte, duplicate, easily cause hepatocellular damage.Acute fatal hepatitis, then jaundice is deepened rapidly, and liver dwindles rapidly, and bleeding tendency is arranged, and ascites, liver is smelly and acute renal failure, and with nervous symptoms.Hepatitis B be virus in hepatocyte by a series of immunoreation, liver is got involved, it is mostly slow fall ill, but treats relatively more difficult.
The method of western medical treatment viral hepatitis is at present: (1) isolates; (2) lie up; (3) with the hepatic treatment, for example use V B, V C, V K4, inosine, glucuronolatone, hepatocyte growth factor etc.; (4) use antiviral drugs such as interferon, polyinosini treatment; (5) with immunoregulation medicament treatment, for example thymosin, transfer factor, polyporusum bellatus etc.Not only the course of treatment is long and trouble, medical expense costliness for the western medicine and medical practitioners method, and cure rate is not high, and easily recurrence can not be effected a radical cure viral hepatitis.
Summary of the invention the present invention combines hereditary recipe with the modern pharmaceutical technology, preparation of a sharp treatment viral hepatitis and preparation method thereof is provided, and accomplishes to eliminate rapidly hepatitis virus, makes the patient produce antibody mediated immunity power, does not recur the radical cure viral hepatitis.
The percentage by weight of the present invention's prescription is:
Herba Artemisiae Scopariae 9-12 Radix viticis negundo 9-12
Herba Plantaginis 7-10 Herba Kalimeridis 7-10
Fructus Gardeniae root 12-16 Fructus Gardeniae 9-12
Radix Gentianae 4-8 Ramulus Salicis Babylonicae 9-12
Rhizoma Seu Herba Pteridis Dactylinae 7-10 Radix Serissae 9-12
Herba Eleusines Indicae 9-12
Preparation method is at first the herbal raw material of cleaned section to be equipped with by above-mentioned prescription, will be equipped with then good raw material through decoct, concentrate, filtered and recycled, drying, granulation process, be packaged into bag after the oven dry, make electuary.Therapeutic Method is to obey electuary hepatitis A patient day three times, and each 20mg takes after mixing it with hot water; To serious symptom type hepatitis, hepatitis B, liver cirrhosis, hepatic ascites patient, can suitably increase the weight of dosage according to physical condition.
Viral hepatitis belongs to the category of Chinese medicine " jaundice ", " costalgia ", " gathering ".The traditional Chinese medical science is thought: viral hepatitis is that the epidemic disease caused by damp-heat pathogen poison is invaded liver and gall, cause suffocating of liver and gall not normal, bile is excessive, it is burnt during damp hinders, influence the taste lifting, causing the fortuneization functional disorder, form phlegm retention and ascites, is the aim for the treatment of primary disease so enzyme falls in clearing away heat-damp and promoting diuresis, dispersing the stagnated liver-QI for regulating the stomach, invigorating the spleen for dissipating phlegm, removing heat from blood jaundice eliminating, detoxifcation.
Treatment principle of the present invention derives from above-mentioned theory of Chinese medical science.The pharmacological action of each component is the effect that Herba Artemisiae Scopariae, Herba Plantaginis have clearing away heat-damp and promoting diuresis detoxifcation jaundice eliminating in the prescription; Herba Eleusines Indicae, Fructus Gardeniae, Rhizoma Seu Herba Pteridis Dactylinae have the merit of heat-clearing and toxic substances removing jaundice eliminating; Fructus Gardeniae root energy removing heat from blood jaundice eliminating, heat-clearing and toxic substances removing; Herba Kalimeridis can the heat clearing away spleen invigorating go to amass; Radix Serissae energy clearing away heat-damp and promoting diuresis soothing liver-QI for relieving depression; Radix viticis negundo has the stomach function regulating damp eliminating effect of reducing phlegm; Radix Gentianae can be held up liver to fall enzyme, fall wadding.Each medicine share then clearing away heat-damp and promoting diuresis, detoxifcation falls that enzyme, dispersing the stagnated liver-QI for regulating the stomach, spleen invigorating eliminate the phlegm, the effect of removing heat from blood jaundice eliminating, Cure Viruses hepatitis effectively.
Compared with prior art, the present invention has following characteristics:
1, the medicine source is extensive, the medicine valency is cheap, helps the treatment of rural area and poverty-stricken area hepatitis.
2, curative effect is reliable, has no side effect short treating period.Can cure fully in general five days hepatitis A; Hepatitis gravis, hepatitis B, liver cirrhosis, hepatic ascites also there is remarkable therapeutic effect.
3, processing technique is simple, patient's taking convenience.
4, can effect a radical cure viral hepatitis, especially hepatitis A be had specially good effect.After patient's recovery from illness,, can not recur again owing to produce antibody mediated immunity power.
Specific embodiment embodiment one
At first be equipped with by the percentage by weight of following prescription herbal raw material with cleaned section:
Herba Artemisiae Scopariae 12 Radix viticis negundos 9 Herba Plantaginiss 10
Herba Kalimeridis 7 Fructus Gardeniae 9 Fructus Gardeniae roots 16
Ramulus Salicis Babylonicae 12 Radix Gentianae 8 Rhizoma Seu Herba Pteridis Dactylinae 10
Radix Serissae 9 Herba Eleusines Indicae 12
To be equipped with then good raw material through decoct, concentrate, filtered and recycled, drying, granulation process, be packaged into bag after the oven dry, make electuary.
Embodiment two
Preparation method is identical with embodiment one, and just the change of the percentage by weight of prescription is as follows:
Herba Artemisiae Scopariae 9 Radix viticis negundos 12 Herba Plantaginiss 7
Herba Kalimeridis 10 Fructus Gardeniae 12 Fructus Gardeniae roots 12
Ramulus Salicis Babylonicae 9 Radix Gentianae 4 Rhizoma Seu Herba Pteridis Dactylinae 7
Radix Serissae 12 Herba Eleusines Indicae 9
Embodiment three
Preparation method is identical with embodiment one, and just the change of the percentage by weight of prescription is as follows:
Herba Artemisiae Scopariae 10 Radix viticis negundos 10 Herba Plantaginiss 7.5
Herba Kalimeridis 7.5 Fructus Gardeniae 7.5 Fructus Gardeniae roots 15
Ramulus Salicis Babylonicae 10 Radix Gentianae 5 Rhizoma Seu Herba Pteridis Dactylinae 7.5
Radix Serissae 10 Herba Eleusines Indicae 10
Embodiment four
Preparation method is identical with embodiment one, and just the change of the percentage by weight of prescription is as follows:
Herba Artemisiae Scopariae 9.7 Radix viticis negundos 9.7 Herba Plantaginiss 8
Herba Kalimeridis 8 Fructus Gardeniae 8 Fructus Gardeniae roots 13
Ramulus Salicis Babylonicae 9 Radix Gentianae 6.5 Rhizoma Seu Herba Pteridis Dactylinae 8
Radix Serissae 9.7 Herba Eleusines Indicae 9.7
Clinical observation report
One, selects the standard of case
Treatment is organized in 220 examples, male's 140 examples, women's 80 examples, age 14-40 one full year of life, average 28.8 one full year of life; Matched group 90 examples, male's 56 examples, women's 34 examples, age 18-45 one full year of life, average 29.4 one full year of life.Two groups of patients all are Hepatitis A through the chemical examination of counties and cities' level the People's Hospital, and two groups of patients have comparability at aspect there was no significant differences (P>0.05) such as age, sex, the state of an illness and the courses of disease.
Two, diagnostic criteria
Draft with reference to the diagnostic criteria of nineteen ninety Shanghai whole nation viral hepatitis academic conference revision and the viral hepatitis treatment scheme (try) of the 5th the national infectious disease parasitic disease academic conference revision in Beijing in May nineteen ninety-five, icteric index is higher, costalgia, asthenia, weak, vomit, detest oil, yellow urine is lacked.Jaundice appears in sclera, skin, and the transaminase raises.
Three, therapeutic scheme design
1, treatment group: use the invention prescription, with Herba Artemisiae Scopariae 20g (10%), Radix viticis negundo 20g (10%), Herba Plantaginis 15g (7.5%), Herba Kalimeridis 15g (7.5%), Fructus Gardeniae root 30g (15%), Fructus Gardeniae 15g (7.5%), Radix Gentianae 10g (5%), Ramulus Salicis Babylonicae 20g (10%), Rhizoma Seu Herba Pteridis Dactylinae 15g (7.5%), Radix Serissae 20g (10%), Herba Eleusines Indicae 20g (10%) juice at a simmer, 1 dose of every day, divide clothes three times, logotype five days.
2, matched group: use quiet of this Yinzhihuang Injection, Vitc2g, inosine 0.8g, oral compound vitamin B, logotype five days.
Four, efficacy assessment standard
Viral hepatitis treatment scheme (trying) with reference to the academic session discussing revision of nineteen ninety-five whole nation infectious disease parasite is drafted.Produce effects: clinical symptom disappearance, liver function and icteric index inspection recover normal.Effectively: cardinal symptom disappears, and liver function test recovers normal or mile abnormality, and icteric index is near normal.Invalid: cardinal symptom does not take a turn for the better, and liver function does not have improvement.
Five, therapeutic outcome (the gained data are summarized) is as follows:
Group ????n Produce effects (%) Effectively (%) Invalid (%) Total effective rate
The treatment group ????220 ?204(92.8%) ??12(5.4%) ??4(1.8%) ????98.2%
Matched group ????90 ?42(46.7%) ??20(22.2%) ??28(31.1%) ????68.9%
Annotate: compare P<0.01 with matched group.

Claims (2)

1, a kind of Chinese herbal and crude drugs preparations for the treatment of viral hepatitis is characterized in that the percentage by weight of each component prescription is:
Herba Artemisiae Scopariae 9-12 Radix viticis negundo 9-12
Herba Plantaginis 7-10 Herba Kalimeridis 7-10
Fructus Gardeniae root 12-16 Fructus Gardeniae 9-12
Radix Gentianae 4-8 Ramulus Salicis Babylonicae 9-12
Rhizoma Seu Herba Pteridis Dactylinae 7-10 Radix Serissae 9-12
Herba Eleusines Indicae 9-12
2, a kind of preparation method for the treatment of the viral hepatitis Chinese herbal and crude drugs preparations, its step are at first to be equipped with by the percentage by weight of the following prescription herbal raw material with cleaned section:
Herba Artemisiae Scopariae 9-12 Radix viticis negundo 9-12
Herba Plantaginis 7-10 Herba Kalimeridis 7-10
Fructus Gardeniae root 12-16 Fructus Gardeniae 9-12
Radix Gentianae 4-8 Ramulus Salicis Babylonicae 9-12
Rhizoma Seu Herba Pteridis Dactylinae 7-10 Radix Serissae 9-12
Herba Eleusines Indicae 9-12
To be equipped with then good raw material through decoct, concentrate, filtered and recycled, drying, granulation process, be packaged into bag after the oven dry, make electuary.
CN 02114047 2002-04-11 2002-04-11 Chinese herbal medicine preparation for curing viral hepatitis and its preapring method Pending CN1377696A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02114047 CN1377696A (en) 2002-04-11 2002-04-11 Chinese herbal medicine preparation for curing viral hepatitis and its preapring method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02114047 CN1377696A (en) 2002-04-11 2002-04-11 Chinese herbal medicine preparation for curing viral hepatitis and its preapring method

Publications (1)

Publication Number Publication Date
CN1377696A true CN1377696A (en) 2002-11-06

Family

ID=4742926

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02114047 Pending CN1377696A (en) 2002-04-11 2002-04-11 Chinese herbal medicine preparation for curing viral hepatitis and its preapring method

Country Status (1)

Country Link
CN (1) CN1377696A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102743656A (en) * 2012-07-26 2012-10-24 李永庆 Chinese medicine for treating hepatitis B
CN105288316A (en) * 2015-12-04 2016-02-03 青岛安倍康生物医药技术有限公司 Goosegrass herb oral liquid with functions of clearing away heat and removing dampness and protecting liver and benefiting gallbladder and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102743656A (en) * 2012-07-26 2012-10-24 李永庆 Chinese medicine for treating hepatitis B
CN102743656B (en) * 2012-07-26 2013-08-14 李永庆 Chinese medicine for treating hepatitis B
CN105288316A (en) * 2015-12-04 2016-02-03 青岛安倍康生物医药技术有限公司 Goosegrass herb oral liquid with functions of clearing away heat and removing dampness and protecting liver and benefiting gallbladder and preparation method thereof

Similar Documents

Publication Publication Date Title
MXPA03003446A (en) Novel medicinal herbal composition for treating liver diseases and hiv.
CN1471953A (en) Medicinal plant composition for treating AIDS patient
CN1698812A (en) Pharmaceutical composition for treating hepatitis B
CN102988948B (en) Medicament for treating infantile suppurative tonsillitis
CN1720965A (en) Chinese medicinal composition for treating acute icterohepatitis
CN116139237B (en) A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application
CN1969940A (en) Antivirus pharmaceutical composition
CN100340286C (en) Medicine for treating hepatitis B and its preparing method
CN1377696A (en) Chinese herbal medicine preparation for curing viral hepatitis and its preapring method
CN1730090A (en) Chinese traditional medicinal composition for treating hepatitis and process for preparing the same
CN1686210A (en) Traditional Chinese medicinal preparation for treating hepatitis B
CN103893634B (en) Traditional Chinese medicine for treating infantile cholestasis
CN1294980C (en) Medicine for treating liver disease
CN1059104C (en) Capsule for anti hepatitis B
CN1292766C (en) Chinese medicinal preparation for treating viral myocarditis and its making method
CN111375036B (en) Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application thereof
CN1101559A (en) Traditional Chinese medicine oral administration liquid for anti-cancer and its preparing method
CN103191386B (en) Medicament for treating chronic hepatitis B
CN1159057C (en) Medicine for treating hepatitis, and preparing process thereof
CN103860964B (en) A kind of medicament for the treatment of adults with Kashin-Beck disease
CN1106856C (en) Hepatosis treating medicine and its preparation
CN1128634C (en) Hepatitis B recuperating medicine granule
CN1352966A (en) Medicine for treating tracheitis and asthma
CN1062167C (en) Hepatitis curing medicine
CN1209131C (en) Medicine 'Yiganjiangmeisan' for treating hepatitis B and its preparing process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication